What is ADMA Biologics's other income (expense)?

ADMA Biologics (ADMA) reported other income (expense) of -$1.15M in Q1 2026.

How has ADMA Biologics's other income (expense) changed year-over-year?

ADMA Biologics's other income (expense) increased by 19.8% year-over-year, from -$1.43M to -$1.15M.

What is the long-term trend for ADMA Biologics's other income (expense)?

Over 4 years (2021 to 2025), ADMA Biologics's other income (expense) has grown at a -9.8% compound annual growth rate (CAGR), from -$13.27M to -$8.79M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

ADMA Biologics ADMA Other Income (Expense)

Other Income (Expense) at other companies

AbCellera Biologics Inc.ABCL

$7.98M-17.5%

AnaptysBio, Inc.ANAB

-$18.21M-55.0%

ZymeworksZYME

$120K+145%

Bio-Rad LaboratoriesBIO

$24.2M-34.9%

Apogee Therapeutics, Inc.APGE

$8.74M+11.5%

Quest DiagnosticsDGX

-$65M+7.1%

Segments

By segment

See full

ADMA Bio Manufacturing-$187K-192%

Plasma Collection Centers$68K—

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's other income (expense)?: ADMA Biologics (ADMA) reported other income (expense) of -$1.15M in Q1 2026.
How has ADMA Biologics's other income (expense) changed year-over-year?: ADMA Biologics's other income (expense) increased by 19.8% year-over-year, from -$1.43M to -$1.15M.
What is the long-term trend for ADMA Biologics's other income (expense)?: Over 4 years (2021 to 2025), ADMA Biologics's other income (expense) has grown at a -9.8% compound annual growth rate (CAGR), from -$13.27M to -$8.79M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.